Flow chart describing study population.

<p>Flow chart describing study population.</p

Kaplan-Meier curves for time to loss to care among those who returned for at least one post-enrollment visit, by pregnancy status at enrollment (N = 2044).

<p>Includes participants who had ≥ 1 follow-up visit after enrollment. Pregnancy status was recorded at enrollment into care. Participants were classified as lost to care (on their last clinic visit) if > 365 days had passed since their last clinic visit. All participants who did not experience the outcome were censored at the date of last clinic visit or when they were no longer at risk for loss to care (365 days before the database closing date).</p

Associations of demographic and clinical characteristics at enrollment and having no follow-up^* after enrollment (N = 2175).

<p>Associations of demographic and clinical characteristics at enrollment and having no follow-up^{<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0195231#t002fn005" target="_blank">*</a>} after enrollment (N = 2175).</p

Associations of demographic and clinical characteristics at enrollment and loss to care among HIV-infected women with at least one visit after enrollment in care (N = 2044).

<p>Associations of demographic and clinical characteristics at enrollment and loss to care among HIV-infected women with at least one visit after enrollment in care (N = 2044).</p

Xpert MTB/RIF utilization and outcomes among 2722 adult patients.

<p>Xpert MTB/RIF utilization and outcomes among 2722 adult patients.</p

Patient characteristics at time of TB diagnosis (n = 2722).

<p>Patient characteristics at time of TB diagnosis (n = 2722).</p

Multivariable modified Poisson regression analysis of factors associated with an unfavorable TB treatment outcome.

<p>Multivariable modified Poisson regression analysis of factors associated with an unfavorable TB treatment outcome.</p

Xpert availability at participating sites.

<p>Xpert availability at participating sites.</p

Number of active children by month of follow-up and HAART status.

<p>The timing of HAART initiation, in addition to the reduction in population size over time due to death, transfer to a different care provider, or loss to follow-up, is illustrated.</p

Participating countries (n = 18) and number of patients included by each.

<p>Map created in July 2016 by Kate Clouse using ArcMap GIS 10.3.1 (Esri, Redlands, CA).</p